Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Javier Garde Noguera
Role of RAS Mutation Status as a Prognostic Factor for Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy Based on Fluoropyrimidines and Oxaliplatin, With or Without Bevavizumab: A Retrospective Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status
Oncology Letters
Cancer Research
Oncology
Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis
World Journal of Surgical Oncology
Surgery
Oncology
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
Clinical Efficacy and Safety of Nimotuzumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer: A Retrospective Analysis
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Significance of Serum Ferritin as a Prognostic Factor in Advanced Hepatobiliary Cancer Patients Treated With Korean Medicine: A Retrospective Cohort Study
BMC Complementary and Alternative Medicine
Medicine
Alternative Medicine
Complementary
First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology